e-learning
resources
Virtual 2020
Pre-Congress Content
Translational science in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of inhaled corticosteroids and a beta-2 agonist on C. pneumoniae-infected airway epithelial cells
D. Paróczai (Deszk, Hungary), D. Kókai (Szeged, Hungary), K. Burián (Szeged, Hungary)
Source:
Virtual Congress 2020 – Translational science in respiratory infections
Session:
Translational science in respiratory infections
Session type:
E-poster session
Number:
2336
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Paróczai (Deszk, Hungary), D. Kókai (Szeged, Hungary), K. Burián (Szeged, Hungary). The effects of inhaled corticosteroids and a beta-2 agonist on C. pneumoniae-infected airway epithelial cells. 2336
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β
2
-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003
The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Lack of glucocorticoid receptor activation by formoterol and salmeterol in human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003
Anti-inflammatory effect of the combination of a long acting beta2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following
Staphylococcus aureus
infection
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Corticosteroids and long-acting beta2 agonist combination restores the airway epithelial cell chloride efflux decreased by
staphylococcus aureus
supernatant
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
Anti-inflammatory effect of the combination of a long acting β2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following
staphylococcus aureus
virulence factors challenge
Source: Eur Respir J 2006; 28: Suppl. 50, 104s
Year: 2006
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC)
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006
Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006
The effects of inhaled glucocorticoids on human neutrophil apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation: is this phenomenon airway remodeling?
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Increased doses of inhaled corticosteroids versus addition of long-acting beta2 agonists for treatment of asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept